Transfemoral transcatheter aortic valve replacement for pure native aortic regurgitation: one-year outcomes of a single-center study

BACKGROUND: Evidence about safety and efficacy of transcatheter aortic valve replacement (TAVR) with the Venus A-Valve system (Venus Medtech, Hangzhou, China) remains limited for patients with pure native aortic regurgitation (PNAR). OBJECTIVES: The single-center study sought to report the one-year...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Hua-Jie, Cheng, Yong-Bo, Yan, Chao-Jun, Lin, De-Qing, Yu, San-Jiu, Li, Jun, He, Ping, Cheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311875/
https://www.ncbi.nlm.nih.gov/pubmed/37386379
http://dx.doi.org/10.1186/s12872-023-03329-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311875/
https://www.ncbi.nlm.nih.gov/pubmed/37386379
http://dx.doi.org/10.1186/s12872-023-03329-1

Ejemplares similares